EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSCMIG00000011147
Gene Symbol: GRIK4
3 Cross references
263 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSCMIG00000001221
Gene Symbol: GRM2
4 Cross references
281 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSCMIG00000001079
Gene Symbol: GRM4
2 Cross references
278 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSCMIG00000013895
Gene Symbol: GRM5
4 Cross references
290 Possible Orthologues:

Glutaminase

Ensembl ID : ENSCMIG00000015272
Gene Symbol: GLS
3 Cross references
312 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSCMIG00000000709
Gene Symbol: GSK3B
3 Cross references
244 Possible Orthologues:

Group 10 Secretory Phospholipase A2-Like

Ensembl ID : ENSCMIG00000016997
Gene Symbol: LOC103190668
4 Cross references
250 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSCMIG00000003846
Gene Symbol: GHRHR
2 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSCMIG00000013335
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCMIG00000010302
Gene Symbol: GUCY1A1
1 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCMIG00000017242
Gene Symbol: GUCY1A2
1 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCMIG00000010317
Gene Symbol: GUCY1B1
4 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).